---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-016047"
form_type: "8-K"
ticker: "LTRN"
cik: "0001763950"
company_name: "Lantern Pharma Inc."
filed_at: "2026-04-10T23:59:59+00:00"
generated_at: "2026-05-15T06:41:41.863849+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Lantern Pharma demonstrates withZeta.ai AI co-scientist platform; no financial data disclosed

## Summary
- Live demo of withZeta.ai, a multi-agentic AI platform for rare cancer drug discovery and clinical design.
- Presentation discussed platform capabilities, commercial architecture, rare cancer market opportunity, and competitive positioning.
- Outlined near-term revenue strategy and growth roadmap for the withZeta.ai platform.
- Replay of the demonstration available at provided Zoom link; presentation furnished as Exhibit 99.1.
- No specific financial or operational metrics were provided in the filing or exhibit.

## SEC filing metadata
- accession: 0001493152-26-016047
- form_type: 8-K
- ticker: LTRN
- cik: 0001763950
- company_name: Lantern Pharma Inc.
- filed_at: 2026-04-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1763950/000149315226016047/0001493152-26-016047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1763950/000149315226016047/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-016047
- JSON: https://secwatch.observer/filing/0001493152-26-016047.json
- Plain text: https://secwatch.observer/filing/0001493152-26-016047.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.